readthroughSign in
CompanyCOCPNasdaqBothell, WA

Cocrystal Pharma, Inc.

Cocrystal Pharma discovers and develops antiviral therapeutics targeting noroviruses, influenza viruses, coronaviruses including SARS-CoV-2, and hepatitis C viruses using structure-based drug design.

10-QNov 16Latest SEC filing
Sep 14Latest story